Compare UCL & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UCL | STSS |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | Hong Kong | United States |
| Employees | N/A | 55 |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.8M | 43.8M |
| IPO Year | 2019 | N/A |
| Metric | UCL | STSS |
|---|---|---|
| Price | N/A | $1.51 |
| Analyst Decision | | |
| Analyst Count | | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | 282.3K |
| Earning Date | 04-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | $0.01 |
| 52 Week High | N/A | $18.23 |
| Indicator | UCL | STSS |
|---|---|---|
| Relative Strength Index (RSI) | 43.59 | 36.26 |
| Support Level | $1.23 | $1.42 |
| Resistance Level | $1.67 | $2.02 |
| Average True Range (ATR) | 0.09 | 0.10 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 47.55 | 1.89 |
Ucloudlink Group Inc is engaged in the provision of data connectivity services and sales of Wi-Fi terminals and data related products to enable personal and enterprise users to access mobile internet in more than 100 countries and areas. Leveraging its inventive cloud SIM technology and architecture, the company redefine the mobile data connectivity experience, allowing users to gain access to mobile data traffic allowance shared by network operators on its marketplace. It has aggregated mobile data traffic allowances from 391 MNOs in 163 countries and regions in its cloud SIM architecture. The company derives maximum revenue from Japan.
Sharps Technology Inc is a medical device and pharmaceutical packaging company offering patented, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. The Company has adopted a digital asset treasury scheme focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.